Catalysts for Par Pharmaceutical Inc

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

Endo USA, Inc. recall (Cls III)

Endo USA, Inc. recall (Cls III)

Endo USA, Inc. recall (Cls III)

Endo USA, Inc. recall (Cls III)

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

Endo USA, Inc. recall (Cls III)

ALVIMOPAN — FDA approval

ALVIMOPAN — FDA approval

STATE UNIVERSITY OF NY,BINGHAMTON — Central Amygdala Vasopressin Activity in Withdrawal-Related Affect from Chron...

Tailstorm Health INC recall (Cls II)

Tailstorm Health INC recall (Cls II)

ENDO USA, Inc. recall (Cls I)

Endo USA, Inc. recall (Cls I)

Endo USA, Inc. recall (Cls I)

Endo USA, Inc. recall (Cls I)

Endo USA, Inc. recall (Cls I)

ALVIMOPAN — FDA approval

ALVIMOPAN — FDA approval

ALVIMOPAN — FDA approval

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

ALVIMOPAN — FDA approval

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

ALVIMOPAN — FDA approval

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval

KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval